Neocortical decreases in synaptic density correlate signifcantly with the cognitive impairment seen in Alzheimer disease. Recently available monoclonal antibodies (MAb) have made possible the highly specific and sensitive detection of synapse-associated proteins in immunocytochemical and immunochemical techniques. We describe a simple yet highly sensitive dot-immunobinding assay for relative quantiftcation of the synapse marker protein synaptophysin in human brain homogenate fractions with the mouse MAb SY38. Fractions prepared from control and Alzheimer specimens were blotted to nitrocellulose membranes and reacted with SY38,
Introduction
Synaptic density measurements in brain sections can be made directly by identification of individual synapses with electron microscopy (2,4) and indirectly by immunocytochemical labeling of synapse-associated proteins (such as synaptophysin) coupled with quantification by laser confocal imaging (9, 11, 17, 18) or optical density measurement (143). Similarly, immunochemical techniques in brain homogenates and fractions can indirectly estimate the density of synapses by Western blot (14) dot-blot (6), radioimmunoassay (19) , and ELISA (25, 27) .
Although immunochemical studies in animal models of denervation have validated indirect assays for estimating synaptic density (12,23), present dot-blot techniques have not been standardized for human brain tissue. The objectives of the present study were to develop a sensitive yet easy to use dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity to complement other, more complicated direct measures of synaptic density and to correlate such a technique with synaptic quantification provided by laser confocal imaging.
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Materials and Methods

Dot-immunobinding Assay
Samples. All tissues were obtained from the Alzheimer Disease Research Center (ADRC) at the University of California, San Diego. Brains were recovered according to a standard protocol (22) . Briefly, brains were removed within 24 hr post mortem and divided sagittally along the midline. The left hemisphere was fixed by immersion in 10% formalin and the right was placed in a heat-sealed pouch for storage at -70'C. In some cases fresh samples were removed from various cortical and subcortical areas and processed immediately. Otherwise, brains were removed from -70'C storage and thawed for 4 hr at 4°C before sampling. Diagnoses were confirmed clinically and histopathologically. Specimens included tissue dissected from the midfrontal area from 27 Alzheimer patients (mean age 78 f 8 years, 6 hr post-mortem interval) and nine control specimens (mean age 75 * 8 years, 13 hr post-mortem time). Particulate fractions were prepared as follows: 0.1 g (wet weight) fresh or frozen tissue was homogenized with a Dounce glass/glass tissue grinder in 0.9 ml cold brain homogenization buffer (NaHzP04 1.85 mM, Na2HP04 8.4 mM, NaCl 15 mM, benzamidine 5 mM, EDTA 3 mM, MgSO4 1 mM, sodium azide 0.05%, pH 8). Homogenates were subjected to low-speed centrifugation (5000 x g x 10 min at 4'C) in a Dupont S o d RCSB rdrigerated centrifuge (Dupont Instruments, Wilmington, DE). The supernatant was then uluacentrifuged (100,000 x g x 1 hr, 4'C) in a Beckman TL.100 Ultracentrifuge (Beckman Instruments; Fullerton, California). The pellet was re-suspended in 200 pl homogenization buffer and sonicated. After total protein determination (10) . samples were diluted to a uniform concentration of 40 pg proteinlml.
Normalization Standard. To allow valid comparison of data from mul-tiple blots, a means of normalizing all data points to a relative standard was devised. Tissue from the midfrontal cortex of a 40-year-old male control case was prepared in identical fashion to the other samples and stored at -7O'C in single-use aliquots (80 pl, 800 pg total protcinlml). For each assay, five serial dilutions of standard were made with equal volumes of standard and homogenization buffer. Ten pI from each dilution provided standard points of 0.25. 0.5, 1.0, 2.0, 4.0, and 8.0 pg total protein. Arbitrary units were assigned to each standard based on 100 Units/pg of protein. Therefore, the standards ranged from 25 to 800 arbitrary units (AU).
Blotting. Blotting of sample and standard protein was accomplished with a 96-well MINIFOLD I microsample filtration manifold (Schlcicher & Schuell; Keene. NH). An 8.5 x 11-cm rectangle of 0.45 pm (pore size) nitrocellulose membrane backed by gel blot filter paper was pre-wetted in (PBS). (NaH2P04 1.86 mM, Na2HP04 8.41 mM. NaCl 150 mM, pH 7.4) and mounted into the blotting manifold. The manifold's vacuum nipple was sealed with paraffin film to preclude seepage through the membrane during subsequent steps. All wells were pre-loaded with 200 pl PBS. Duplicate test samples of 12.5. 25. and 50 pl each (0.5, 1.0. 2.0 pg protein). and 10 pI of each normalization standard (scven standards including blank) were pipetted into appropriate wells. Two 50-pl aliquots from each sample dilution were taken for total protein assay to make corrections for total protein during final data expression. Samples were then drawn through the nitroccllulosc by application of the house vacuum, followed by a 300-pl wash of PBS into each well. The blot was removed from the filtration manifold and dried under a lamp for 5 min before incubation in PBS-Tween blocking solution (0.1% Tween-20 in PBS, pH 7.4) for 2 hr at 4'C.
Detection of Synaptophysin. The mouse monoclonal antibody (MAb) SY38 against synaptophysin (Boehringer; Mannheim. Germany) has been extensively characterized elsewhere (7.14.26). All incubations were carried out on a motorized rocking platform at 4°C in PBS plus 3% bovine serum albumin (PBS-BSA. pH 7.4). Blots were incubated overnight with MAb SY38 at 0. Autoradiography and Quantification. To produce a permanent visual record. blots were autoradiographed with Kodak RP-X-omat film in cassettes with Dupont Cronex intensifying screens. Individual dots were then cut from the blot and counted on a Ga"aTrac 1193 (TM Analytic; Elk Grove Village, IL) equipped with curve-fitting software. A sofrwarc protocol was created to construct the standard curve by plotting the log of the standard concentration (in AU) on the X-axis and radiation counts (CPM) on the Yaxis, and then fining a line through the points using a cubic spline function. The program then used the curve to estimate sample concentration (in AU) from CPM data. Spreadsheet softwarr (Microsoft Excel; Microsoft Corporation, Rcdmond, WA), was used to correct for the differing protein concentrations of the sample dilutions, and to calculate the means. standard deviations (SD), and percent coefficient of variation (%CV). Results were expressed as AU per 1 pg protein.
Immunocytocbemistry/Laser Confocal Imaging/ Computer-aided Quantification
Immunofluorescent Labeling. Bridly, as previously described (11) . vibratome sections from the frontal cortex of the cases analyzed by dot-blot were placed in PBS. PBS-Triton X (0.1%). PBS-HzOz (3%), blocked with 5 % normal hone serum, and then incubated overnight at 4'C with SY38 at a concentration of 1 pglml. This step was followed by incubation in FITCtagged horse anti-mouse IgG (Vector Labs; Burlingame, CA) 1:lOO. The i"unolabelcd sections were transferred to SuperFrost slides (Fisher; Tustin, CA) and mounted under glass coverslips with anti-fading medium (4% n-propyl gallate) (Sigma; St Louis. MO). All sections were processed simultaneously under the same conditions. The immunofluorescent labeling protocol was repeated to assess the reproducibility of results.
Laser Confocal Imaging. As previously described (11) . the immunolabeled sections were viewed with a Zeiss 63X (NA 1.4) objective on a Zeiss Axiovert 35M microscope (Obcrkochen, Germany) with attached laxr confocal scanning system MRC 600 (Bio-Rad; Wattford, UK). From maintaining the same gain, aperture, and black level settings. These detection parameters were d u a t e d in previous studies and yield consistent results in linear range (17) while maintaining a low background. We determined that quenching of the fluorescence was not a significant concern by testing the effect of different periods of laser exposure on signal detected. using the #2 position (3% transmission) neutral density filter and degassed antifading medium. The digitized video images were processed and stored on 650 Mbyte rewritable optical disk cartridges.
Computer-aided Quantification of Synaptophysin-hunodve
Nerve Terminals. Quantitative analysis of optically sectioned images displaying the presynaptic terminals was carried out as previously described (11) with the aid of the Image (Figure 2 ).
Since the present technique was developed as an adjunct to and as an immunochemical analogue of liser confocal imaging (Figure  3) , the degree of positive correlation between these two techniques was of prime interest. The correlation coefficient for 20 pairs of samples for which both techniques were employed was r = 0.821 (p<O.OOl) (Figure 4 ).
Discussion
The principal advantages of the present technique are economy and simplicity. The primary antibody concentration of 0.1 pglml is at least an order of magnitude less than the 2 pg/ml concentration required by ELISA methods (27). Brain fraction preparation requires only two centrifugation steps and small tissue quantities of 0.1 g (or less) are sufficient. The use of a relative standard obviates the need for a complex series of purification steps from synaptic vesicles, as performed by others (6,7,26). Our experience with MAb sY38 in Westem blots has shown it to be highly specific, recognizing intensely a single band at 38 KD, with virtually all the immunoreactivity localized to the particulate as opposed to the cytosolic fraction (IS). Furthermore, immunoelectron microscopy in human brain has confirmed the synaptic vesicle location of synaptophysin (13). Given these characteristics, we concluded that the use of a semi-crude preparation as a normalization standard was justified, although we readily acknowledge that synthetic or purified synaptophysin would be a more useful standard in that it would yield an absolute concentration and allow comparability among results from other laboratories. The system has proven robust and reproducible. Preparations of tissue taken at different time intervals from specimens kept at 4°C (to stimulate the conditions of increasing post-mortem delay) showed stable immunoreactivity for up to 48 hr (unpublished data). Likewise, varying the concentrations of different reagents, such as protein A, did not affect the relative response of sample and standard and therefore did not alter the results. The strongly significant positive correlation between this dot-blot assay and the synaptic density measurements obtained by computer-aided confocal microscopy further validates the reliability of this technique.
The 40% drop in synaptophysin immunoreactivity in the Alzheimer cases compared with control values is consistent with the 34-47% decline (in midfrontal cortex) previously reported by our group (14J6). Results of electron microscopy studies have varied from no detectable loss (1) to a 2546% decrease, depending on which neocortical layer is studied (3,20) . Recent reports are less varied and support a 30-50% synaptic decline in Alzheimer neocortex (5,8,21,24 ).
In conclusion, given a proper regard for the inherent limitations of using a relative calibration standard, the present method provides a rapid, sensitive, yet simple to employ means for quantification of synaptophysin-like immunoreactivity in human brain.
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